NO20021900L - FremgangsmÕte for analyse av forbindelsers hormonvirkning - Google Patents

FremgangsmÕte for analyse av forbindelsers hormonvirkning

Info

Publication number
NO20021900L
NO20021900L NO20021900A NO20021900A NO20021900L NO 20021900 L NO20021900 L NO 20021900L NO 20021900 A NO20021900 A NO 20021900A NO 20021900 A NO20021900 A NO 20021900A NO 20021900 L NO20021900 L NO 20021900L
Authority
NO
Norway
Prior art keywords
protein
dna
arap11
fragments
modulator
Prior art date
Application number
NO20021900A
Other languages
English (en)
Other versions
NO20021900D0 (no
Inventor
Maik Obendorf
Siegmund Wolf
Der Jens Schr
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10121710A external-priority patent/DE10121710A1/de
Priority claimed from DE2001161325 external-priority patent/DE10161325A1/de
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Publication of NO20021900D0 publication Critical patent/NO20021900D0/no
Publication of NO20021900L publication Critical patent/NO20021900L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Sampling And Sample Adjustment (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20021900A 2001-05-04 2002-04-22 FremgangsmÕte for analyse av forbindelsers hormonvirkning NO20021900L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10121710A DE10121710A1 (de) 2001-05-04 2001-05-04 Verfahren zur Testung des hormonellen Effekts von Substanzen
DE2001161325 DE10161325A1 (de) 2001-12-13 2001-12-13 Verfahren zur Testung des hormonellen Effekts von Substanzen

Publications (2)

Publication Number Publication Date
NO20021900D0 NO20021900D0 (no) 2002-04-22
NO20021900L true NO20021900L (no) 2002-11-05

Family

ID=26009230

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021900A NO20021900L (no) 2001-05-04 2002-04-22 FremgangsmÕte for analyse av forbindelsers hormonvirkning

Country Status (10)

Country Link
US (1) US20030124508A1 (no)
EP (1) EP1255113B1 (no)
JP (1) JP4071033B2 (no)
AT (1) ATE267402T1 (no)
DE (1) DE50200452D1 (no)
DK (1) DK1255113T3 (no)
ES (1) ES2219601T3 (no)
NO (1) NO20021900L (no)
PT (1) PT1255113E (no)
TR (1) TR200402024T4 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10226674B4 (de) * 2002-06-12 2006-01-05 Schering Ag Verfahren zur Testung des hormonellen Effekts von Substanzen
DE10226675B4 (de) * 2002-06-12 2006-01-05 Schering Ag Verfahren zur Testung des hormonellen Effekts von Substanzen
EP2316328B1 (en) 2003-09-15 2012-05-09 Super Dimension Ltd. Wrap-around holding device for use with bronchoscopes
ES2387026T3 (es) 2003-09-15 2012-09-11 Super Dimension Ltd. Dispositivo de fijación envolvente para utilizarse con broncoscopios
US8764725B2 (en) 2004-02-09 2014-07-01 Covidien Lp Directional anchoring mechanism, method and applications thereof
US7655700B2 (en) 2005-08-25 2010-02-02 Michigan State University Transgenic mouse model and methods for treatment of neuro muscular disease by interfering with androgen-androgen receptor interaction in skeletal muscles
US8905920B2 (en) 2007-09-27 2014-12-09 Covidien Lp Bronchoscope adapter and method
US8932207B2 (en) 2008-07-10 2015-01-13 Covidien Lp Integrated multi-functional endoscopic tool
US10582834B2 (en) 2010-06-15 2020-03-10 Covidien Lp Locatable expandable working channel and method
US10952593B2 (en) 2014-06-10 2021-03-23 Covidien Lp Bronchoscope adapter
US10426555B2 (en) 2015-06-03 2019-10-01 Covidien Lp Medical instrument with sensor for use in a system and method for electromagnetic navigation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506102A (en) * 1993-10-28 1996-04-09 Ligand Pharmaceuticals Incorporated Methods of using the A form of the progesterone receptor to screen for antagonists of steroid intracellar receptor-mediated transcription

Also Published As

Publication number Publication date
ATE267402T1 (de) 2004-06-15
JP4071033B2 (ja) 2008-04-02
DE50200452D1 (de) 2004-06-24
EP1255113B1 (de) 2004-05-19
DK1255113T3 (da) 2004-10-04
NO20021900D0 (no) 2002-04-22
PT1255113E (pt) 2004-10-29
ES2219601T3 (es) 2004-12-01
US20030124508A1 (en) 2003-07-03
TR200402024T4 (tr) 2004-09-21
JP2003018996A (ja) 2003-01-21
EP1255113A1 (de) 2002-11-06

Similar Documents

Publication Publication Date Title
Kloepper et al. Methods in hair research: how to objectively distinguish between anagen and catagen in human hair follicle organ culture
Cervellati et al. Oxidative damage and the pathogenesis of menopause related disturbances and diseases
NO20021900L (no) FremgangsmÕte for analyse av forbindelsers hormonvirkning
Boss et al. Uncoupling protein-3 expression in skeletal muscle and free fatty acids in obesity
NO984856D0 (no) Innretning for kvalitativ og/eller kvantitativ analyse av analytter, basert pÕ f°lsom magnetisk deteksjon
ATE378418T1 (de) Extrazelluläres, neues rage-bindendes protein (en-rage) und dessen verwendungen
IS4971A (is) Aðferð til að greina ástand lífveru með mælingu ápeptíðum
DE60106228D1 (de) Elektrochemischer biosensor-teststreifen mit erkennungselektrode und auslesemessgerät, das diesen teststreifen verwendet
Steinkellner et al. A high throughput electrochemiluminescence assay for the quantification of frataxin protein levels
Casbarra et al. Conformational analysis of HAMLET, the folding variant of human α‐lactalbumin associated with apoptosis
ATE490469T1 (de) Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden
AR035956A1 (es) Deteccion y cuantificacion de isoformas de prion en enfermedades neurodegenerativas mediante espectrometria de masas.
Kito et al. Downregulation of the Ca2+-activated K+ channel KCa3. 1 in mouse preosteoblast cells treated with vitamin D receptor agonist
CA2377815C (en) Fluorescent intensity method for assaying binding between proteins or peptides
Maleknia et al. Unfolding of apomyoglobin helices by synchrotron radiolysis and mass spectrometry
Parwanto et al. The effect of sex hormone binding globulin (SHBG) protein polymorphism on the levels of SHBG, testosterone, and insulin in healthy Indonesian men
ATE294395T1 (de) Verfahren zur testung des hormonellen effekts von substanzen
Netuschil et al. Vital fluorescence to assess in vitro and in vivo the antibacterial effects of amalgams.
PT1047777E (pt) Novas moleculas de acidos nucleicos correlacionadas com o fenotipo rhesus d fraco
Morange et al. Ala147Thr and C+ 1542G polymorphisms in the TAFI gene are not asssociated with a higher risk of venous thrombosis in FV Leiden carriers
Phillips et al. Inducible nuclear factors binding the IgM heavy chain pre‐mRNA secretory poly (A) site
Tan et al. Modulation of BmK AS, a scorpion neurotoxic polypeptide, on voltage-gated Na+ channels in B104 neuronal cell line
Oh et al. Development of filtration-based time-resolved fluorescence assay for the high-throughput screening of urotensin II receptor antagonist
HUP0203269A2 (en) Method for the detection of mammalian carcinomas
EP1376136A3 (de) Verfahren zur Testung des hormonellen Effekts von Substanzen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application